title: Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
authors.affiliation: Dept. of Pediatrics, School of Medicine, University of Milan, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Borzani
authors.forename: F
authors.initials: F
authors.lastname: Varotto
authors.forename: L
authors.initials: L
authors.lastname: Garlaschi
authors.forename: F
authors.initials: F
authors.lastname: Conio
authors.forename: M
authors.initials: M
authors.lastname: Dell'Olio
authors.forename: P
authors.initials: P
authors.lastname: Careddu
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004917:Erythromycin / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D015644:Miocamycin / Q000627:therapeutic use*; D013290:Streptococcal Infections / Q000188:drug therapy*; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D015644:Miocamycin; D004917:Erythromycin